EPB41L4A
protein-codingerythrocyte membrane protein band 4.1 like 4A, the group of FERM domain containing
Gene summary
The protein encoded by this gene is a member of the band 4.1 protein superfamily. Members of this superfamily are thought to play an important role in regulating interactions between the cytoskeleton and plasma membrane, and contain an amino terminal conserved domain that binds glycophorin C. This gene product is thought to be involved in the beta-catenin signaling pathway. [provided by RefSeq, Dec 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~276.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EPB41L4A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022140.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 4 | 2 | 8 | ||
| missense | 1 | 119 | 8 | 3 | 131 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 9 | 9 | ||||
| Total | 0 | 2 | 130 | 12 | 5 | 149 |
Highest pathogenic variant AF is 0.000013014539
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_071423.4 | 23 | MANE Select | |
| Ensembl | ENSP00000261486.5 | 23 | MANE Select | |
| RefSeq | NP_001334816.1 | 24 | Standard | |
| RefSeq | NP_001334817.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- biological_process
- actomyosin structure organization
Molecular Function
- molecular_function
- cytoskeletal protein binding
Cellular Component
- cellular_component
- cytoplasm
- cytoskeleton
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261486
- Coding exons
- 23
- Length
- 276876
- Individuals with no LoFs
- 124624
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 175
- Defined
- 124799
- p
- 0.000701
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.26 | 451 | 382 | 1.18 | 0.0000219 | 4460 |
| Missense (PolyPhen) | 149 | 132.53 | 1.1242 | 1443 | ||
| Synonymous | -1.54 | 158 | 135 | 1.17 | 0.00000773 | 1251 |
| Loss of Function | 1.46 | 38 | 49.1 | 0.774 | 0.00000277 | 567 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.00030 | 0.00029 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00057 | 0.00056 | rare |
| Finnish | 0.00042 | 0.00042 | rare |
| European (Non-Finnish) | 0.00082 | 0.00082 | rare |
| South Asian | 0.00093 | 0.00092 | rare |
| Other | 0.00066 | 0.00066 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- LoFtool
- 0.255
- RVIS EVS
- 1.61
- RVIS percentile EVS
- 95.91
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.128
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |